Medication info

Valtrex 10/160/10 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tabletRosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
Kyungdong Pharmaceutical Co., Ltd.
Appearance
Pink, egg-shaped, bilaterally convex film-coated tablet
Packaging
30 tablets per bottle
Approval status
Active

MFDS item code 202006710 · Approved 2020.09.29 · Insurance code 648104550

Summary

Main use
Treatment of hypertension, improvement of dyslipidemia, inhibition of atherosclerosis progression and cardiovascular disease risk
Who takes it
Adults
Adult dose
Take 1 tablet once daily with water. If possible, it is recommended that the tablet be taken at the same time each day (e.g., before breakfast). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and rosuvastatin. For patients taking the amlodipine/valsartan combination together with rosuvastatin as separate products, switching to this medicine (a combination product containing the same amount of each active ingredient) may be considered for convenience. ▷ Amlodipine/valsartan combination Before starting the amlodipine/valsartan combination, it is recommended that the dose of the individual component (amlodipine or valsartan) be adjusted. However, if blood pressure is not controlled with monotherapy using either component, switching directly to the amlodipine/valsartan combination may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose. ▷ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which is adequate for most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or longer according to LDL cholesterol levels, the treatment goal, and the patient's response; it may be increased to a maximum of 20 mg daily. 2. Elderly patients: No dosage adjustment is necessary. 3. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering rosuvastatin 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of rosuvastatin is contraindicated in some of these patients.

Ingredients

Manufacturer
Kyungdong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension, improvement of dyslipidemia, inhibition of atherosclerosis progression and cardiovascular disease risk

  • Essential hypertension
  • primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • primary dysbetalipoproteinemia
  • elevated high-sensitivity C-reactive protein levels
  • hypertension
  • low HDL cholesterol levels
  • smoking
  • family history of early coronary artery disease
View approved original text

This medicine is used for patients who require simultaneous administration of amlodipine/valsartan combination and rosuvastatin. First, amlodipine and valsartan are used to treat essential hypertension and are effective when blood pressure is not adequately controlled with monotherapy. Rosuvastatin assists in the treatment of hypercholesterolemia and dyslipidemia and is used as an adjunct when controlled by diet and exercise alone is insufficient. It is also helpful in patients with homozygous familial hypercholesterolemia and primary dysbetalipoproteinemia. This medicine is used to lower total cholesterol and LDL cholesterol levels to delay the progression of atherosclerosis and reduce the risk of stroke, myocardial infarction, and revascularization procedures. Therefore, this medicine effectively improves cardiovascular disease risk by managing blood pressure and blood lipids together.

How to take

Adult dose

Take 1 tablet once daily with water. If possible, it is recommended that the tablet be taken at the same time each day (e.g., before breakfast). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and rosuvastatin. For patients taking the amlodipine/valsartan combination together with rosuvastatin as separate products, switching to this medicine (a combination product containing the same amount of each active ingredient) may be considered for convenience. ▷ Amlodipine/valsartan combination Before starting the amlodipine/valsartan combination, it is recommended that the dose of the individual component (amlodipine or valsartan) be adjusted. However, if blood pressure is not controlled with monotherapy using either component, switching directly to the amlodipine/valsartan combination may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose. ▷ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which is adequate for most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or longer according to LDL cholesterol levels, the treatment goal, and the patient's response; it may be increased to a maximum of 20 mg daily. 2. Elderly patients: No dosage adjustment is necessary. 3. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering rosuvastatin 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of rosuvastatin is contraindicated in some of these patients.

Precautions

This medicine can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with an allergy to any ingredient of this medicine or similar drugs, in pregnant or breastfeeding women, or in patients with severe liver or kidney disease. Patients with dehydration or low sodium should correct their condition before taking this medicine, and vital signs and physical condition should be closely monitored during treatment. Patients with high potassium levels should exercise caution when taking potassium supplements or potassium-sparing drugs with this medicine, and regular monitoring of blood potassium levels is necessary. Patients with renal issues or kidney transplant recipients must closely monitor kidney function when using this medicine. If angioedema occurs while taking this medicine, discontinue use immediately, and re-administration is prohibited. Patients with heart failure or myocardial infarction must carefully monitor kidney function and cardiac status while using this medicine. Muscle-related side effects such as myalgia, myopathy, or rhabdomyolysis may arise while taking this medicine, so if muscle pain or weakness occurs, please inform healthcare providers immediately. Elderly patients may be more sensitive to this medicine; starting at a lower dose and monitoring condition is advisable. Caution is needed when driving or operating machinery, as dizziness or fatigue may occur. There may be interactions when this medicine is combined with other specific drugs; inform healthcare providers about any other medications being taken. Do not use this medicine while pregnant or breastfeeding, and women planning a pregnancy should use appropriate contraception. This medicine is not recommended for pediatric patients, as safety and efficacy have not been established. In case of overdose, severe hypotension or cardiovascular side effects may occur, so it is crucial to adhere strictly to the dosage and seek medical attention immediately in case of overdose.

Side effects

Dizziness, perceptual abnormality, chest discomfort, chills, increased ALT, increased AST, weight gain, upper respiratory infection, myalgia, palpitations, ventricular ectopy, diarrhea, duodenitis, gastritis, dyspnea, blepharospasm, eyelid edema, hypertriglyceridemia, benign prostatic hyperplasia, nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, drowsiness, orthostatic dizziness, sensory abnormality, vertigo, tinnitus, tachycardia, chest palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, nausea, abdominal pain, constipation, thirst, rash, erythema, hyperhidrosis, rash, pruritus, joint swelling, low back pain, arthritis, muscle cramps, weakness, frequent urination, polyuria, erectile dysfunction, edema, scrotal edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, chest pain, pain, nocturia, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremor, taste abnormality, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, myocardial infarction, vasculitis, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, urination disorders, gynecomastia, pain, malaise, weight loss, serum sickness, increased serum potassium, vasculitis, elevated liver function tests, bullous dermatitis, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, polyneuropathy, amnesia, peripheral neuropathy, thrombocytopenia, jaundice, eosinophilia with systemic symptoms associated with drug reaction syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, headache, increased ALT, chest pain, cough, myalgia, increased CK, dizziness, constipation, increased AST, weakness, joint pain, fatigue, numbness, sensory abnormality, chest discomfort, nausea, appetite loss, abdominal distension, pruritus, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine may be sensitive to air and moisture; therefore, it should be stored in a tightly sealed container. It is important to maintain storage temperatures between 1°C and 30°C. This will help preserve the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

Pink, egg-shaped, bilaterally convex film-coated tablet

Package unit

30 tablets per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.